X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (26310) 26310
Book Review (6588) 6588
Publication (2145) 2145
Newsletter (1688) 1688
Newspaper Article (335) 335
Magazine Article (136) 136
Book Chapter (134) 134
Conference Proceeding (81) 81
Book / eBook (51) 51
Transcript (49) 49
Trade Publication Article (30) 30
Dissertation (8) 8
Data Set (6) 6
Government Document (2) 2
Reference (2) 2
Report (2) 2
Web Resource (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22196) 22196
index medicus (21974) 21974
antiviral agents - therapeutic use (11931) 11931
male (11192) 11192
female (11105) 11105
antiviral agents (10927) 10927
adult (8796) 8796
middle aged (8296) 8296
antiviral agents - adverse effects (7113) 7113
treatment outcome (5350) 5350
health aspects (5077) 5077
hepatitis c, chronic - drug therapy (4652) 4652
hiv (4581) 4581
drug therapy (4347) 4347
antiviral agents - administration & dosage (4340) 4340
drug therapy, combination (4316) 4316
infectious diseases (4261) 4261
gastroenterology & hepatology (4019) 4019
hepatitis c (4017) 4017
aged (3695) 3695
infection (3590) 3590
pharmacology & pharmacy (3581) 3581
hiv infections - drug therapy (3464) 3464
care and treatment (3366) 3366
therapy (3314) 3314
hepatitis c virus (3164) 3164
risk factors (3142) 3142
research (2956) 2956
interferon (2925) 2925
interferon-alpha - therapeutic use (2892) 2892
ribavirin (2858) 2858
immunology (2854) 2854
virology (2848) 2848
animals (2817) 2817
analysis (2815) 2815
ribavirin - therapeutic use (2709) 2709
hepatitis (2605) 2605
hiv infection (2433) 2433
highly active antiretroviral therapy (2424) 2424
interferon-alpha - adverse effects (2420) 2420
adolescent (2361) 2361
virus diseases (2308) 2308
antiviral agents - pharmacology (2301) 2301
transplantation (2267) 2267
human immunodeficiency virus--hiv (2246) 2246
abridged index medicus (2241) 2241
viral load (2235) 2235
infections (2171) 2171
aids (2127) 2127
hepatitis c - drug therapy (2120) 2120
hepacivirus - genetics (2078) 2078
recombinant proteins (2037) 2037
genotype (2025) 2025
virus-infection (1946) 1946
viruses (1898) 1898
retrospective studies (1896) 1896
young adult (1839) 1839
medical research (1838) 1838
microbiology (1809) 1809
antiretroviral therapy (1808) 1808
ribavirin - adverse effects (1773) 1773
dosage and administration (1748) 1748
time factors (1730) 1730
medicine, general & internal (1570) 1570
prevention (1570) 1570
hepacivirus - drug effects (1515) 1515
liver (1512) 1512
polyethylene glycols - therapeutic use (1509) 1509
disease (1508) 1508
hepatitis b (1508) 1508
hiv patients (1505) 1505
medicine & public health (1504) 1504
child (1486) 1486
medicine, experimental (1480) 1480
hepatitis b, chronic - drug therapy (1467) 1467
antiretroviral drugs (1439) 1439
prospective studies (1419) 1419
antiviral therapy (1403) 1403
hiv infections - complications (1395) 1395
biological response modifiers (1387) 1387
patients (1386) 1386
mortality (1381) 1381
clinical trials (1366) 1366
aids/hiv (1359) 1359
complications and side effects (1358) 1358
ribavirin - administration & dosage (1358) 1358
medicine (1329) 1329
anti-hiv agents - therapeutic use (1315) 1315
interferon-alpha - administration & dosage (1303) 1303
human-immunodeficiency-virus (1282) 1282
hepatitis c, chronic - virology (1265) 1265
efficacy (1247) 1247
drugs (1231) 1231
surgery (1217) 1217
recurrence (1210) 1210
anti-hiv agents (1207) 1207
research article (1172) 1172
protease inhibitors (1162) 1162
virus (1150) 1150
safety (1139) 1139
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (37) 37
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Online Resources - Online (2) 2
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27319) 27319
Spanish (259) 259
French (258) 258
German (219) 219
Japanese (154) 154
Chinese (128) 128
Russian (71) 71
Polish (44) 44
Korean (36) 36
Italian (34) 34
Dutch (27) 27
Danish (24) 24
Hungarian (22) 22
Swedish (15) 15
Czech (10) 10
Norwegian (10) 10
Portuguese (9) 9
Serbian (8) 8
Croatian (6) 6
Hebrew (5) 5
Finnish (4) 4
Romanian (4) 4
Slovak (4) 4
Ukrainian (3) 3
Bulgarian (2) 2
Turkish (2) 2
Icelandic (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2012, Volume 366, Issue 3, pp. 216 - 224
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1594 - 1603
In this trial in previously untreated patients with HCV genotype 1 infection and no cirrhosis, high rates of sustained response were achieved with three new... 
TRIAL | MEDICINE, GENERAL & INTERNAL | PLUS SOFOSBUVIR | C VIRUS-INFECTION | GENOTYPE 1 INFECTION | DACLATASVIR | SIMEPREVIR TMC435 | HEPATITIS-C | INTERFERON-FREE | TREATMENT-NAIVE PATIENTS | PHASE 2B | Anilides - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Viral Load | Young Adult | Ritonavir - adverse effects | Ritonavir - therapeutic use | Adult | Female | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Uracil - therapeutic use | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Macrocyclic Compounds - therapeutic use | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Adolescent | Sulfonamides - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Drug Combinations | Uracil - analogs & derivatives | Dosage and administration | Research | Drug therapy, Combination | Hepatitis C | Drug therapy | Ribavirin | Ritonavir | Body weight | Diarrhea | Infections | Nausea | Proteinase inhibitors | Pruritus | Drug resistance | Patients | Genotype & phenotype | Cirrhosis | Sleep disorders | Hepatitis | Asthenia | Hemoglobin | Interferon | Drug dosages | Genotypes | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 20, pp. 1878 - 1887
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1604 - 1614
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 147, Issue 2, pp. 359 - 365.e1
Background & Aims The interferon-free regimen of ABT-450 (a protease inhibitor), ritonavir, ombitasvir (an NS5A inhibitor), dasabuvir (a non-nucleoside... 
Gastroenterology and Hepatology | IFN | PEARL-II | Ribavirin-Free | Interferon-Free Therapy | PLUS RIBAVIRIN | ABT-450/R-OMBITASVIR | VIRUS-INFECTION | TELAPREVIR | SOFOSBUVIR | CHRONIC HEPATITIS-C | COMBINATION | TRIAL | CIRRHOSIS | BOCEPREVIR | GASTROENTEROLOGY & HEPATOLOGY | Anilides - therapeutic use | Puerto Rico | Hepatitis C - drug therapy | United States | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Viral Load | Ritonavir - adverse effects | Time Factors | Ritonavir - therapeutic use | Adult | Female | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Europe | Ribavirin - therapeutic use | Uracil - therapeutic use | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Biomarkers - blood | Macrocyclic Compounds - therapeutic use | Hepatitis C - diagnosis | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Carbamates - adverse effects | Hepacivirus - growth & development | Aged | Carbamates - therapeutic use | Uracil - analogs & derivatives | Medical colleges | Care and treatment | Proteases | Ritonavir | Biological products industry | Genetic aspects | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2134 - 2146
In two trials involving patients with hepatitis C in whom previous treatment with direct-acting antiviral agents failed, treatment for 12 weeks with... 
GENOTYPE 1 | MEDICINE, GENERAL & INTERNAL | THERAPY | HEPATITIS-C VIRUS | EFFICACY | PROTEASE INHIBITOR GS-9857 | RESISTANCE | DIRECT-ACTING ANTIVIRALS | OPEN-LABEL | COMBINATION | PHASE-2 TRIAL | Hepatitis C - drug therapy | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Male | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Aged, 80 and over | Adult | Female | Hepatitis C - complications | Sofosbuvir - adverse effects | Protease Inhibitors - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Liver Cirrhosis - etiology | Antiviral Agents - therapeutic use | Genotype | Heterocyclic Compounds, 4 or More Rings - adverse effects | Macrocyclic Compounds - adverse effects | Macrocyclic Compounds - therapeutic use | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Hepatitis C - virology | Sulfonamides - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Viral Nonstructural Proteins - antagonists & inhibitors | Drug Combinations | Care and treatment | Hepatitis C virus | Drug therapy | Patients | Health aspects | Headache | Antiretroviral drugs | Antiviral agents | Proteinase | Clinical trials | Diarrhea | Fatigue | Nausea | Cirrhosis | Hepatitis | Genotypes | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 20, pp. 1889 - 1898
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 21, pp. 1973 - 1982
Journal Article